These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 9769082)
1. Equine peripheral blood mononuclear cells proliferate in response to tetanus toxoid antigen. McKelvie J; Little S; Foster AP; Cunningham FM; Hamblin A Res Vet Sci; 1998; 65(1):91-2. PubMed ID: 9769082 [TBL] [Abstract][Full Text] [Related]
2. In vitro production of specific antibody by equine peripheral blood mononuclear cells using tetanus toxoid as a recall antigen. O'Brien MA; Holmes MA; Duffus WP Res Vet Sci; 1992 Sep; 53(2):184-90. PubMed ID: 1439208 [TBL] [Abstract][Full Text] [Related]
4. CD154 Expression Indicates T Cell Activation Following Tetanus Toxoid Vaccination of Horses. Schnabel CL; Fletemeyer B; Lübke S; Marti E; Wagner B; Alber G Front Immunol; 2022; 13():805026. PubMed ID: 35493462 [TBL] [Abstract][Full Text] [Related]
5. Detection of tetanus toxoid-specific memory T cells in equine lymph nodes but not in peripheral blood. Frayne J; Stokes CR Res Vet Sci; 1995 Jul; 59(1):79-81. PubMed ID: 8525091 [TBL] [Abstract][Full Text] [Related]
6. Assessing immune competence in pigs by immunization with tetanus toxoid. Gimsa U; Tuchscherer A; Gimsa J; Tuchscherer M Animal; 2018 Jan; 12(1):116-121. PubMed ID: 28554336 [TBL] [Abstract][Full Text] [Related]
7. Antigen-induced IL-17 response in the peripheral blood mononuclear cells (PBMC) of healthy controls. Lenarczyk A; Helsloot J; Farmer K; Peters L; Sturgess A; Kirkham B Clin Exp Immunol; 2000 Oct; 122(1):41-8. PubMed ID: 11012616 [TBL] [Abstract][Full Text] [Related]
8. Culicoides antigen extract stimulates equine blood mononuclear (BMN) cell proliferation and the release of eosinophil adherence-inducing factor(s). Mckelvie J; Foster AP; Hamblin AS; Cunningham FM Res Vet Sci; 2001 Apr; 70(2):115-22. PubMed ID: 11356090 [TBL] [Abstract][Full Text] [Related]
9. Cytokine synthesis analyzed at the single-cell level before and after revaccination with tetanus toxoid. Fernandez V; Andersson J; Andersson U; Troye-Blomberg M Eur J Immunol; 1994 Aug; 24(8):1808-15. PubMed ID: 8056039 [TBL] [Abstract][Full Text] [Related]
10. Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni. Sabin EA; Araujo MI; Carvalho EM; Pearce EJ J Infect Dis; 1996 Jan; 173(1):269-72. PubMed ID: 8537675 [TBL] [Abstract][Full Text] [Related]
11. An in vitro immune response model to determine tetanus toxoid antigen (vaccine) specific immunogenicity: Selection of sensitive assay criteria. Piersma SJ; Leenaars MP; Guzylack-Piriou L; Summerfield A; Hendriksen CF; McCullough KC Vaccine; 2006 Apr; 24(16):3076-83. PubMed ID: 16504349 [TBL] [Abstract][Full Text] [Related]
12. Differential efficacy of lymphocyte- and monocyte-selective pretreatment with a type 4 phosphodiesterase inhibitor on antigen-driven proliferation and cytokine gene expression. Essayan DM; Huang SK; Kagey-Sobotka A; Lichtenstein LM J Allergy Clin Immunol; 1997 Jan; 99(1 Pt 1):28-37. PubMed ID: 9003208 [TBL] [Abstract][Full Text] [Related]
13. The induction and suppression of in vitro IgG anti-tetanus toxoid antibody synthesis by human lymphocytes stimulated with tetanus toxoid in the absence of in vivo booster immunizations. Lum LG; Culbertson NJ J Immunol; 1985 Jul; 135(1):185-91. PubMed ID: 2582031 [TBL] [Abstract][Full Text] [Related]
14. Decreased in vitro cellular response to tetanus toxoid and tuberculin in patients using topical corticosteroids. Wang G; Molander G; Koivuluhta M; Alenius H; Lauerma A Acta Derm Venereol; 2005; 85(4):296-8. PubMed ID: 16191848 [TBL] [Abstract][Full Text] [Related]
15. In vitro effect of interleukin-12 on antigen-specific lymphocyte proliferative responses from persons infected with human immunodeficiency virus type 1. Uherova P; Connick E; MaWhinney S; Schlichtemeier R; Schooley RT; Kuritzkes DR J Infect Dis; 1996 Sep; 174(3):483-9. PubMed ID: 8769604 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory activity of fenoterol on Dermatophagoides-, Parietaria-, tetanus-toxoid-, and Candida albicans-stimulated blood mononuclear cells: differences in beta2-adrenoreceptor stimulation but not in cell apoptosis. Silvestri M; Oddera S; Scarso L; Pistoia V; Tasso P; Rossi GA J Asthma; 2000 May; 37(3):281-90. PubMed ID: 10831153 [TBL] [Abstract][Full Text] [Related]
17. An optimized assay for the enumeration of antigen-specific memory B cells in different compartments of the human body. Cao Y; Gordic M; Kobold S; Lajmi N; Meyer S; Bartels K; Hildebrandt Y; Luetkens T; Ihloff AS; Kröger N; Bokemeyer C; Atanackovic D J Immunol Methods; 2010 Jun; 358(1-2):56-65. PubMed ID: 20302874 [TBL] [Abstract][Full Text] [Related]
18. Participation of CD1 molecules in the presentation of bacterial protein antigens in humans. Ulanova M; Tarkowski A; Hahn-Zoric M; Hanson LA Scand J Immunol; 1999 Oct; 50(4):387-93. PubMed ID: 10520178 [TBL] [Abstract][Full Text] [Related]
19. Cellular immune responses to beta casein: elevated in but not specific for individuals with Type I diabetes mellitus. Ellis TM; Ottendorfer E; Jodoin E; Salisbury PJ; She JX; Schatz DA; Atkinson MA Diabetologia; 1998 Jun; 41(6):731-5. PubMed ID: 9662058 [TBL] [Abstract][Full Text] [Related]
20. In vitro IgM rheumatoid-factor production induced by tetanus toxoid. Levinson AI; Tar L J Allergy Clin Immunol; 1988 Apr; 81(4):730-6. PubMed ID: 3258604 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]